After your clinical evaluation, your doctor will provide a prescription and advise on the most appropriate formulation based on quality, dosing, and your specific clinical needs
Semaglutide has been shown to produce more frequent incidences of gallbladder issues compared to tirzepatide, with it being 2.6 times more likely to cause cholelithiasis, demonstrating an increased biliary risk
Summary: GLP-1 medications slow gut motility and gastric emptying, leading to harder stools and constipation, which can be managed through increased dietary fibre, adequate hydration, regular physical activity, and appropriate laxative use when necessary
It is bad news for Novo, but good news for patients: A course of Wegovy costs hundreds of dollars a month